Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

mannkind and onedrop partnership
$599
Posted in: Bolus Insulin, Glucose Monitoring, Topics May 04 | 2017Mannkind and One Drop enter collaboration for better diabetes outcomesPurchase Blast
lexicon cover image
$599
Posted in: SGLT2i, Topics May 03 | 2017Lexicon Q1 ’17 Earnings UpdatePurchase Blast
lilly cover image
$599
Posted in: Bolus Insulin, DPP-IVi, GLP-1RA, GLP-1RA + Basal, SGLT2i, Topics Apr 25 | 2017Lilly Q1 ’17 Earnings UpdatePurchase Blast
lilly cover image
$599
Posted in: DPP-IVi, Other, SGLT2i, Topics Apr 19 | 2017Lilly Initiates Ph1 for New OADPurchase Blast
JnJ cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery, SGLT2i, Topics Apr 18 | 2017J&J Q1 ’17 Earnings UpdatePurchase Blast
lilly cover image
$599
Posted in: Basal Insulin, GLP-1RA, SGLT2i, Topics Mar 24 | 2017Lilly Increases Diabetes Manufacturing Investment in 2017Purchase Blast
sansum and lilly cover image
$599
Posted in: GLP-1RA, GLP-1RA + Basal, SGLT2i, Topics Mar 23 | 2017Lilly Partners with Sansum for Diabetes Research in the Latino PopulationPurchase Blast
mannkind cover image
$599
Posted in: Bolus Insulin, Topics Mar 08 | 2017MannKind Sponsors Reality TV ShowPurchase Blast
lexicon cover image
$599
Posted in: SGLT2i, Topics Mar 03 | 2017Lexicon Q4 ’16 Earnings UpdatePurchase Blast
mylan cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Topics Mar 01 | 2017Mylan Q4 ’16 Earnings and Investor Day UpdatePurchase Blast
merck cover image
$599
Posted in: DPP-IVi, SGLT2i, Topics Feb 02 | 2017Merck Q4 ’16 Earnings UpdatePurchase Blast
1 93 94 95

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.